HYDROCHLOROTHIAZIDE AUROVITAS
25MG TBL NOB 40
SÚKL code | 0228276 |
---|---|
Name of the product | HYDROCHLOROTHIAZIDE AUROVITAS |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | HYDROCHLOROTHIAZIDE AUROVITAS |
Supplement | 25MG TBL NOB 40 |
Strenght | 25MG |
Pharmaceutical form | Tablet |
Package | 40 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM) |
ATC group | C03AA03 |
ATC group name | HYDROCHLOROTHIAZID |
Doping | Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
Registration Number | 50/ 043/18-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 04. 2020 |
MA Holder | Aurovitas Pharma Polska Sp. z o.o., Warszawa |
MA Holder country | POLSKO |
Actual MA holder | Aurovitas, spol. s r.o., Praha |
Actual MA holder country | ČESKÁ REPUBLIKA |